Investigational Site Number 380002

Bergamo 24127

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Hematopoietic Neoplasm

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed